These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9269524)

  • 1. Order form for restricting vancomycin prescribing.
    Burke CE; Piper J; Holloway W
    Am J Health Syst Pharm; 1997 Aug; 54(16):1893, 1897. PubMed ID: 9269524
    [No Abstract]   [Full Text] [Related]  

  • 2. Limiting vancomycin use to combat vancomycin-resistant Enterococcus faecium.
    Belliveau PP; Rothman AL; Maday CE
    Am J Health Syst Pharm; 1996 Jul; 53(13):1570-5. PubMed ID: 8809278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a patient-focused, interdisciplinary antimicrobial management program involving staff pharmacists.
    Lacy MK; Swartz MA; Eidem LA; Bond JA
    Am J Health Syst Pharm; 1997 Aug; 54(16):1837-41. PubMed ID: 9269521
    [No Abstract]   [Full Text] [Related]  

  • 4. Effectiveness of pharmacy policies designed to limit inappropriate vancomycin use: a population-based assessment.
    Thomas AR; Cieslak PR; Strausbaugh LJ; Fleming DW
    Infect Control Hosp Epidemiol; 2002 Nov; 23(11):683-8. PubMed ID: 12452297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A vancomycin monitoring program at a community hospital.
    Goeckner BJ; Hendershot E; Scott K; Drake M
    Jt Comm J Qual Improv; 1998 Jul; 24(7):379-85. PubMed ID: 9689571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effective management of DUE (drug utilization evaluation) policy through a pharmacy clerkship.
    Julius HC
    Hosp Formul; 1993 Sep; 28(9):789-91. PubMed ID: 10128394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical decision process model for evaluating vancomycin use with modified HICPAC guidelines. Hospital Infection Control Practice Advisory Committee.
    Salemi C; Becker L; Morrissey R; Warmington J
    Clin Perform Qual Health Care; 1998; 6(1):12-6. PubMed ID: 10177043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic cost savings from formulary restrictions and physician monitoring in a medical-school-affiliated hospital.
    Woodward RS; Medoff G; Smith MD; Gray JL
    Am J Med; 1987 Nov; 83(5):817-23. PubMed ID: 3674089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of Investigation of MRSA Susceptibility to Vancomycin in Clinical Units of Large Multifunctional Hospital and Recommendations on Optimization of Antibacterial Therapy of Staphylococcal Infection].
    Verikovsky VA; Minakov OE; Denisova OI; Bondarenko EV
    Antibiot Khimioter; 2015; 60(11-12):35-8. PubMed ID: 27141645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of guidelines on vancomycin use at a Hong Kong teaching hospital.
    Lee VW; Lyon DJ; Fung KS; Leung TP; Ng JK; You JH
    Am J Health Syst Pharm; 2003 May; 60(9):949-50. PubMed ID: 12756948
    [No Abstract]   [Full Text] [Related]  

  • 11. Vancomycin use in a university medical center: comparison with hospital infection control practices advisory committee guidelines.
    Beidas S; Khamesian M
    Infect Control Hosp Epidemiol; 1996 Dec; 17(12):773-4. PubMed ID: 8985761
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacist interventions to improve prescribing of vancomycin and tobramycin.
    Fletcher CV; Giese RM; Rodman JH
    Am J Hosp Pharm; 1986 Sep; 43(9):2198-201. PubMed ID: 3766572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of an aminoglycoside order review process in a central dispensary.
    Zelenitsky SA; Richard A
    Can J Hosp Pharm; 1993 Dec; 46(6):269-74. PubMed ID: 10131345
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of an antibiotic restriction policy using a special drug request form.
    Julius HC; Beck K
    Hosp Formul; 1992 Jun; 27(6):638-40, 643. PubMed ID: 10118958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin control measures at a tertiary-care hospital: impact of interventions on volume and patterns of use.
    Singer MV; Haft R; Barlam T; Aronson M; Shafer A; Sands KE
    Infect Control Hosp Epidemiol; 1998 Apr; 19(4):248-53. PubMed ID: 9605273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital.
    Yeung SS; Yeung JK; Lau TT; Forrester LA; Steiner TS; Bowie WR; Bryce EA
    J Clin Pharm Ther; 2015 Dec; 40(6):655-60. PubMed ID: 26547905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin in Oregon: who's using it and why.
    Cieslak PR; Strausbaugh LJ; Fleming DW; Ling JM
    Infect Control Hosp Epidemiol; 1999 Aug; 20(8):557-60. PubMed ID: 10466557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a vancomycin restriction policy on ordering practices during an outbreak of vancomycin-resistant Enterococcus faecium.
    Anglim AM; Klym B; Byers KE; Scheld WM; Farr BM
    Arch Intern Med; 1997 May; 157(10):1132-6. PubMed ID: 9164379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America.
    Marr JJ; Moffet HL; Kunin CM
    J Infect Dis; 1988 May; 157(5):869-76. PubMed ID: 3361154
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications and impact of prior authorization policy on vancomycin use at a tertiary pediatric teaching hospital.
    Chan S; Hossain J; Di Pentima MC
    Pediatr Infect Dis J; 2015 May; 34(5):506-8. PubMed ID: 25379832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.